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a b s t r a c t
Objective: In this study of patients with chronic periodontitis (CP), the severity of the disease
and the main periodontal pathogens identified in patients with chronic kidney disease
(CKD) were compared with those detected in individuals without systemic disease.
Design: Nineteen patients with CP without evidence of systemic disease (control group), 25
patients with CP and CKD who were in the pre-dialysis stages (pre-dialysis group), and 22
patients with CP and CKD who were on renal replacement therapy (RRT group) were
examined. The severity of CP was based on the investigation of probing depth (PD) and
clinical attachment level (CAL). The definition and stage of CKD were based on the criteria
proposed by the Kidney Disease Outcomes Quality Initiative of the National Kidney Foun-
dation. Glomerular filtration rate (GFR) was estimated using the equation of Modification of
Diet in Renal Disease and the identification of microorganisms in subgingival plaque was
performed using polymerase chain reaction (PCR).
Results: Candida albicans, Porphyromonas gingivalis, Tannerella forsythia, and Treponema denti-
cola were more common in patients who were on RRT and pre-dialysis than in control
subjects. CP was more severe in patients with CKD. A strong association was observed
between the frequency of C. albicans (P = 0.056), P.gingivalis (P = 0.008), T. denticola (P = 0.013)
and CAL, when CKD patients were compared with the control group.
Conclusion: CP is more severe and is associated with increased frequency of C. albicans, P.
gingivalis, T. forsythia, and T. denticola in patients with CKD.
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Chronic kidney disease (CKD) is a generic term and includes a
variety of renal pathologies that determine the progressive* Corresponding author at: Rua Ivan Soares de Oliveira 234, Parque Im
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Open access under the Elsevier OA license.loss of glomerular filtration rate (GFR). Currently, CKD is a
public health problem worldwide. For example, a study by
Coresh et al.1 that evaluated 13,233 participants from 1999 to
2004 revealed that CKD stages 3 and 4 were diagnosed in 7.7%perial, CEP 36036350, Brazil. Tel.: +55 032 3216 2515;
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The similarity of causes and risk factors between CKD in Brazil
and in other countries suggests that the disease is also highly
prevalent in Brazil.2
Recently, an assessment of 12,947 individuals who partici-
pated in the NHANES III study identified periodontal disease as
a potential risk factor for CKD.3 Chronic periodontitis (CP) is an
infectious disease caused by Gram-negative bacteria that
destroy the supporting tissues of the teeth. The presence of
these bacteria in subgingival biofilm causes the release of
proteolytic enzymes that are capable of degrading gingival
tissue.4 Periodontal pathogens not only induce inflammation
and local tissue destruction, but are also associated with
systemic inflammation. Recent studies have shown an
association between elevated levels of C-reactive protein
and periodontitis,4–6 which decreases after nonsurgical peri-
odontal treatment.7,8
The mechanism of systemic response to periodontal
pathogens seems to involve the spread of bacteria, antigens,
endotoxins, and inflammatory cytokines through the circula-
tory system.9 Because gingival tissue is a source of chronic
systemic inflammation, it is biologically plausible to accept CP
as a risk factor for CKD. For example, Kshirsagar et al.10
observed that a GFR <60 mL/min/1.73 m2 was associated with
mild CP after adjusting for risk factors such as cardiovascular
disease (CVD) and CKD (odds ratio, 2.00; 95% Confidence
Interval, 1.23–3.2), and severe CP (odds ratio, 2.14; 95%
Confidence Interval, 1.19–3.85).
There have been few studies on oral microbiota in patients
with CKD and CP. Castillo et al.11 compared the main
periodontal pathogens using the technique of polymerase
chain reaction (PCR) in subgingival dental plaque samples
isolated from 52 CKD patients on hemodialysis with those
from 52 individuals without systemic disease. The authors
found no significant correlation between the frequency of
periodontal pathogens and CKD, as well as no relationship
between the severity of CP (represented by clinical attachment
level or CAL  3 mm) and these microorganisms.
The second study evaluated the composition of sub-
gingival microbiota in 81 patients with CKD (not yet on
dialysis and undergoing hemodialysis) with that in 62
systemically healthy individuals by performing PCR with
the gingival crevicular fluid (smokers and prosthesis users
were included). The authors found that Tannerella forsythia,
Treponema denticola, Prevotella nigrescens, and Candida albicans
were more frequent in patients with CKD than in the
controls.12
Infection is a frequent complication in patients with CKD
and constitutes the second leading cause of death in patients
undergoing renal replacement therapy (RRT) in Brazil.13 The
increased susceptibility of patients with CKD to infection
seems to be related to the degree of immunocompromisation
associated with uremia,14 which is very similar to that
observed in patients with acquired immunodeficiency who
are undergoing immunosuppressive treatment. Therefore, in
this study of patients with chronic periodontitis (CP), the
severity of the disease and the main periodontal pathogens
identified in patients with chronic kidney disease (CKD) were
compared with those detected in individuals without
systemic disease.2. Materials and methods
2.1. Study population
The study was approved by the Ethics Committee in Human
Research of the Federal University of Juiz de Fora (UFJF), MG,
Brazil, and was a cross-sectional study in which dental
evaluations were performed in 359 patients between July
2007 and April 2009. Clinical assessments were performed at
the Dental Clinic of Periodontology and at the Chronic Kidney
Disease Programme of the University Hospital of UFJF.
Inclusion criteria were: age above 18 years, and the presence
of CP (an clinical attachment level 6 mm in two or more teeth
and a probing depth (PD) 5 mm in one or more sites of the
tooth).15 The patients also had to sign the Free and Informed
Consent Form.
Exclusion criteria were: subjects undergoing periodontal
treatment in the previous six months; a history of smoking;
use of antimicrobial and anti-inflammatory drugs during the
six months prior to the study; pregnant or lactating women;
uncontrolled diabetics; HIV carriers; and patients with other
infections or fever of unknown origin. Only 93 patients met our
inclusion criteria. Of these, 27 were excluded for the following
reasons: 20 patients on dialysis were hospitalized or had
complications at the time of dental evaluation, one patient
died, and six patients refused to participate. Of the 66 CP
patients, 19 had no clinical evidence of systemic disease
(control group), 25 patients had CKD in the pre-dialysis stages
(pre-dialysis group), and 22 patients had end stage renal
failure and were undergoing peritoneal dialysis or hemodial-
ysis (RRT group).
2.2. Medical and dental examinations
All participants received medical evaluation, which consisted of
obtaining demographic data and performing physical and
laboratory tests of blood (creatinine, blood count, glucose)
and urine (abnormal elements and sediment). Glomerular
filtration rate (GFR) was estimated using the abbreviated
Modification of Diet in Renal Disease formula: GFR (mL/min
per 1.73 m2) = 186  serum creatinine (mg/dL)1.154  age
(years)0.203  1.212 (if black)  0.742 (if female).16 The diagnosis
and stage of the CKD were established as recommended by US
National Kidney Foundation: kidney damage (such as albumin-
uria or glomeruar hematuria or structural abnormalities as
noted on imaging studies) or a GFR less than 60 mL/min per
1.73 m2 for more than 3 months.17
Diabetes mellitus was diagnosed when fasting blood
glucose levels were 126 mg/dl or 200 mg/dL 2 h after an
overload of 75 g of oral glucose or when using an oral
hypoglycemic medication or insulin (Guideline: Treatment
and follow up of diabetes mellitus).18
Periodontal examination was conducted by a single blind
experienced periodontist. All teeth, except the third molars,
were examined.15 PD and gingival recession were measured in
six sites per tooth (mesio-buccal, mild-buccal, disto-buccal,
mesio-lingual, mild-lingual, and disto-lingual) using a milli-
metre periodontal probe (FP-W, Hu Friedy Manufacturing Inc.,
Chicago, IL). Measurements were made in millimetres. CAL
was calculated as the distance from the cemento-enamel
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to the long axis of the tooth. The study also included other
clinical measurements, such as number of sites with bacterial
plaque19 and number of sites with bleeding on probing
(BOP).19
Periapical radiographs were performed using the parallel-
ism technique, to determine bone loss and to exclude
periapical lesions.
2.3. Collection of subgingival biofilm
Collection of subgingival plaque was performed using Gracey
curettes (Hu Friedy Manufacturing Inc., Chicago, IL) that had
been sterilized previously.20 Isolation of the field with sterile
cotton was performed before the procedure and the periodon-
tal clinical measurements, and supragingival plaque was
removed using a sterile gauze. The subgingival plaque
(biofilm) was removed from the apical region20; however, a
deeper probing depth of 5 mm was adopted.
Biofilm collected from the periodontal pocket was quickly
transferred to microtubes containing 200 mL of lysis solution
(10 mM Tris, 1.0 mM EDTA, 1.0% Triton X-100, pH 7.8). The
material was kept in a freezer at 20 8C until used for the
extraction of bacterial DNA.
2.4. PCR analysis
Bacterial DNA was extracted according to the methodology
proposed by Yuan et al.20: the frozen subgingival plaque
sample was mixed with 250 mL lysis buffer (10 mM Tris,
1.0 mM EDTA, 1% Triton X-100, pH 7.8), boiled for 10 min,
cooled to room temperature, centrifuged at 14,000 rpm for
3 min, and the supernatant was collected as the PCR template.
PCR was performed using specific primers for regions of
DNA encoding 16S rRNA segments for the following speciesTable 1 – Primers for PCR analysis of periodontal pathogens.
Periodontal
pathogens
Primer sequences
(50 ! 30)
C. albicans F 50–GCC GGT GAC GAC GCT CCA AGA GC
R 50–CCG TGT TCA ATT GGG TAT CTC AA
F. nucleatum F 50–AGA GTT TGA TCC TGG CTC AG–30
R 50–GTC ATC GTG CAC ACA GAA TTG CT
E. corrodens F 50–CGA TTA GCT GTT GGG CAA CTT–30
R 50–ACC CTC TGT ACC GAC CAT TGT AT
P. nigrescens F 50–ATG AAA CAA AGG TTT TCC GGT AA
R 50–CCC ACG TCT CTG TGG GCT GCG A–3
A. actinomycetemcomitans F 50–AAA CCC ATC TCT GAG TTC TTC TTC
R 50–ATG CCA ACT TGA CGT TAA AT–30
T. denticola F 50–TAA TAC ATG TGC TCA TTT ACA T–3
R 50–TCA AAG CAT TCC CTC TTC TCC TTA
P. gingivalis F 50–AGG CAG CTT GCC ATA CTG CG–30
R 50–ACT GTT AGC AAC TAC CGA TGT–30
T. forsythia F 50–GCG TAT GTA ACC TGC CCG CA–30
R 50–TGC TTC AGT GTC AGT TAT ACC T–3
P. intermedia F 50–TTT GTT GGG GAG TAA AGC GGG–30
R 50–TCA ACA TCT CTG TAT CCT GCG T–3and according to methodologies described in the literature:
Candida albicans,21 Fusobacterium nucleatum,22 Aggregatibacter
actinomycetemcomitans, Prevotella nigrescens, Prevotella interme-
dia, Eikenella corrodens, Porphyromonas gingivalis, Treponema
denticola, and Tannerella forsythia23 (Table 1).
The reactions were performed in a final volume of 25 mL
using 2  PCR MASTER MIX (50 mM KCl, 10 mM Tris–HCl pH
8.5, 3 mM MgCl2, 400 mM of each dATP, dTTP, dCTP, dGTP, and
Taq DNA polymerase – Promega Corporation1, Madison, WI),
0.5 mM of each primer (IDT-Integrated DNA Technologies Inc.,
Coralville, IA) and 3 mL of a suspension of bacterial DNA. The
reactions were performed in a thermocycler (Techne1 TC-412
Thermal Cycler) under conditions that were determined for
each amplification reaction, as described in Table 1 and in
accordance with published protocols.
PCR amplicons obtained in each reaction were visualized
on 2% agarose gels in 0.5  TBE. Gels were analysed in an
ultraviolet-light transilluminator after treatment with methyl
bromide, using a 100 bp DNA ladder (Promega Corporation1,
Madison, WI) as molecular weight marker.
2.5. Statistical analyses
The results are presented as means  standard deviation (SD)
for numerical variables and as absolute and relative frequen-
cies for categorical variables. Concerning the clinical and
laboratory characteristics and periodontal indexes, the groups
were compared using the chi-squared and Mann–Whitney
tests. Comparison of the frequency of periodontal pathogens
was performed using the chi-squared test. We used the Mann–
Whitney test to compare CAL in the cases that were positive
for the main periodontal pathogens. Differences were consid-
ered significant at P values <0.05. Statistical analyses were
performed using the SPSS software, version 13.0 (SPSS Version
13.0, SPSS, Chicago, IL).Amplicons
size
Amplification
conditions
T G–30 158 bp Initial denaturation: 94 8C, 2 min;
35 cycles of:
G GTC–30 94 8C, 30 s; 56 8C, 30 s; 72 8C, 1 min;
360 bp Final extension: 72 8C, 10 min25
G–30
410 bp
–30
G–30 804 bp Initial denaturation: 94 8C, 2 min;
35 cycles of:
0 94 8C, 30 s; 55 8C, 30 s; 72 8C, 1 min;
–30 557 bp Final extension: 72 8C, 10 min26
0 316 bp
–30
404 bp Initial denaturation: 94 8C, 2 min;
35 cycles of:
94 8C, 30 s; 55 8C, 30 s; 72 8C, 1 min;
641 bp Final extension: 72 8C, 10 min26
0
575 bp
0
Table 2 – Clinical and biochemical characteristics.
Control group
(n = 19)
Pre-dialysis group
(n = 25)
P-Value RRT group
(n = 22)
P-Value
Age (years)a 46  11 56  13 0.01* 56  10 0.015**
Sex
Male (%) 31.6 76 0.04* 41 0.38**
CKD etiology (%)
Hypertension NA 42 9 0.015***
Diabetic renal disease NA 0 27 0.006***
Glomerulonephritis NA 21 36 0.243***
Others NA 37 28 0.655***
SBP (mmHg)a 123  13 152  17 0.001* 147  28 0.001**
DBP (mmHg)a 80  7 90  12 0.001* 86  12 0.087**
Diabetics (%) 0 24 0.77* 36 0.65**
Assessed glomerular filtration (mL/min/1.73 m2)a 156  34 31  18 0.001* NA 0.001**
a Mean  standard deviation.
* P value between pre-dialysis and control groups.
** P value between RRT and control groups.
*** P value between RRT and pre-dialysis group.
CKD: chronic kidney disease; SBP: systolic blood pressure; DBP: diastolic blood pressure; NA: not applicable.
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The clinical, biochemical, and periodontal characteristics of
the study groups are shown in Tables 2 and 3. The age of the
patients was similar in the two chronic kidney groups. Male
patients (76%) predominated in the pre-dialysis group. There
was no difference of socioeconomic status amongst groups.
The main causes of CKD in the pre-dialysis patients were
hypertension (42%) and glomerulonephritis (21%). In patients
on RRT, the main causes of CKD were glomerulonephritis
(36%) and diabetic renal disease (27%).
The mean systolic and diastolic blood pressures were
higher in CKD patients who were on pre-dialysis and RRT than
in healthy subjects. The GFR was higher in healthy subjects
(156  34 mL/min/1.73 m2) than in patients with CKD who
were on pre-dialysis (31  18 mL/min/1.73 m2). GFR was not
determined in patients on RRT.
The average number of teeth was significantly different
between patients who were on RRT and those in the control
group (16  7.6 vs 22  6.3, P < 0.05). The frequency of sites
with plaque in the control group (30  0.3%) did not differ from
that in the pre-dialysis group (36.6  0.6%; P = 0.48), but was
significantly different from that observed in the RRT group
(66.6  0.6%; P = 0.001). The frequency of sites with PD 5 mmTable 3 – Analysis of periodontal indexes according to the stu
Control group
(n = 19)
Pre-dia
(n
Mean number of teetha 22  6.3 24
Sites with bacterial plaque (%) 30  0.3 36.6
Sites with BOP (%) 24.8  30 25.6
PD (mm)a 2.4  0.7 3
Sites with PD 5 mm (%) 8.3  7.7 21.8
Sites with CAL 6 mm (%) 6.7  8.5 10.4
a Mean  standard deviation.
* P value between pre-dialysis and control groups.
** P value between RRT and control groups.
BOP: bleeding on probing; PD: probing depth; CAL: clinical attachment lewas significantly lower in the control group (8.3  7.7%) than
in the pre-dialysis group (21.8  23.4%; P = 0.01), and was
not significantly different from that of the RRT group
(14.1  14.6%; P = 0.28); however, the frequency of sites with
CAL  6 mm of the control group (6.7  8.5 mm) was lower to
that of the pre-dialysis group (10.4  11 mm; P = 0.38) and
was significantly different from that of the RRT group
(26.7  27.8 mm; P = 0.001). These findings suggest the pres-
ence of more severe periodontitis in patients with CKD.
Table 4 shows the frequency of microorganisms, as
assessed by PCR, according to the classification of microbial
complexes proposed by Socransky et al.24. In the control
group, E. corrodens was the most prevalent pathogen (18
patients), followed by P. gingivalis (13 patients), P. nigrescens and
T. denticola (seven patients), T. forsythia (six patients), C. albicans
(five patients), and F. nucleatum (one patient). In this group, we
did not detect the presence of P. intermedia or A. actinomyce-
temcomitans in any individual. In the pre-dialysis group, E.
corrodens was also the most prevalent pathogen (23 patients),
followed by P. gingivalis (18 patients), C. albicans (13 patients), T.
denticola (11 patients), T. forsythia and P. nigrescens (nine
patients), F. nucleatum (four patients), P. intermedia (three
patients), and A. actinomycetemcomitans (one patient). In
contrast, the most frequent periodontal pathogen in thedy group.
lysis group
 = 25)
P-Value RRT group
(n = 22)
P-Value
  4.8 0.552* 16  7.6 0.020**
  0.6 0.481* 66.6  0.6 0.001**
  29 0.915* 36.1  26 0.050**
  1.4 0.050* 2.5  0.7 0.518**
  23.4 0.014* 14.1  14.6 0.284**
  11 0.380* 26.7  27.8 0.001**
vel.
Table 4 – Frequency of periodontal pathogens according to study group.
Control group
(n = 19)
Pre-dialysis
group (n = 25)
P-Value RRT group
(n = 22)
P-Value
Red complex
P. gingivalis (%) 72.2 94.7 0.078* 100 0.013**
T. forsythia (%) 33.3 39.1 0.479* 68.2 0.030**
T. denticola (%) 36.8 44 0.434* 68.2 0.045**
Orange complex
F. nucleatum (%) 5.3 16 0.270* 13.6 0.361**
P. intermedia (%) 0 13.6 0.156* 13.6 0.156**
P. nigrescens (%) 38.9 39.1 0.621* 63.6 0.107**
Green complex
E. corrodens (%) 94.7 95.8 0.694* 95.5 0.718**
A. actinomycetemcomitans (%) 0 4 0.568* 9.1 0.282**
Fungus: C. albicans (%) 26.3 52 0.079* 72.7 0.004**
* P value between pre-dialysis and control groups.
** P value between RRT and control groups.
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corrodens (21 patients), C. albicans (16 patients), T. forsythia and
T. denticola (15 patients), P. nigrescens (14 patients), F. nucleatum
and P. intermedia (three patients), and A. actinomycetemcomitans
(two patients). Although the frequency of these pathogens was
higher in the CP and CKD patient groups than in the control
group, significance was reached only for the results pertaining
to C. albicans, P. gingivalis, T. forsythia, and T. denticola.
The frequency of Candida albicans associated with CP was
assessed in CKD patients with and without diabetes mellitus.
Interesting, Candida albicans was more frequently isolated in
CKD patients without diabetes than in those with diabetes,
although we did not find statistical difference between the
groups.
The presence of C. albicans (Fig. 1), P. gingivalis (Fig. 2), and T.
denticola (Fig. 3) was associated with higher mean values of
CAL in patients with CP and CKD who were in the pre-dialysis
and RRT groups.Fig. 1 – CAL in patients that were positive for C. albicans
between the control, pre-dialysis, and RRT groups. Values
represent medians and quartiles. *P = 0.056 when
comparing the RRT vs the control groups.4. Discussion
In the present study, CP was associated with a higher
frequency of red-complex pathogens (P. gingivalis, T. forsythia,
and T. denticola) and C. albicans in patients with CKD than in
individuals without systemic disease. Additionally, CP was
most severe in the presence of advanced loss of renal function,
i.e., CKD stage 3, 4, or 5 and in patients on RRT.
CKD is a condition of progressive and irreversible loss of
kidney function, resulting in decreased glomerular filtration
rate. The mechanisms of continuous loss of kidney function
identified frequently in CKD include renal hyperfiltration
states and increased intraglomerular pressure, arterial hyper-
tension, renin–angiotensin system activation, proteinuria,
and renal ischemia, amongst others.25
Cardiovascular complications and infectious disease are
common during the course of CKD and are associated with
adverse clinical outcomes. In Brazil, infectious complications
are the second most frequent cause of death in patients with
CKD and RRT,13 probably because of the presence of an
immunocompromised state associated with uremia.14 The
abnormalities in both cellular and humoral immunity and
phagocytic activity, which have been described in vitro and
in vivo26–30 as being associated with uremic status, may
explain the increased frequency of red-complex bacteria
(P. gingivalis, T. forsythia, and T. denticola) and C. albicans in
patients with CP and CKD compared with subjects without
systemic disease.
The oral cavity harbours a large number of microorgan-
isms, including bacterial species, viruses, mycoplasma, and
fungi. The subgingival plaque biofilm is a closed matrix of
bacterial populations that adhere to each other or to a
surface.24 The frequency of C. albicans in the oral cavity is
very high (ranging from 25 to 75%) and is more frequent in
patients who use dentures.31,32 In addition, C. albicans is often
associated with opportunistic infections in patients with
immunodeficiency disease, such as in CKD patients.33 Our
results shows that C. albicans was isolated more frequently,
although without statistical significance, from CKD patients
without diabetes. Logistic Regression showed no association
between age and sex and the isolation of C. albicans (data not
presented). Together, these data suggest that CKD, and not
Fig. 2 – Comparison of CAL in patients who were positive
for P. gingivalis between the control, pre-dialysis, and RRT
groups. Values represent medians and quartiles. #P = 0.029
when comparing the pre-dialysis group with control
group; *P = 0.008 when comparing the RRT group with
control group.
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periodontum. This propose that antifungal medications
should be administered when CP occurs in patients with CKD.
Davidovich et al.34 observed an association between
elevated levels of gingival inflammation and PD across an
entire spectrum of CKD patients when these patients were
compared with healthy subjects. Shultis et al.35 observed anFig. 3 – Comparison of CAL in patients who were positive
for T. denticola between the control, pre-dialysis, and RRT
groups. Values represent medians and quartiles. *P = 0.013
when comparing the RRT group with the control group.association between diabetic renal disease and CP. Recently,
we observed an association between elevated serum levels of
CRP and CKD patients in pre-dialysis who had the most
widespread form of CP.36
Fisher et al.3 identified CP as an independent risk factor for
CKD, after adjustment for traditional and nontraditional risk
factors. In our study, we observed that the markers of more
severe CP were more frequent in patients with CKD. The
nature of the study, however, which was based on a single
evaluation of CP, did not allow us to establish that CP was a
definitive risk factor for CKD.
CP causes the destruction of periodontal ligament and
alveolar bone, favouring the loss of teeth.37 The smaller
number of teeth in CKD patients than in control subjects,
which was possibly due to the greater severity of CP in the
former, is consistent with previous findings for patients with
renal disease.10,35,38 This finding may have clinical relevance,
particularly in light of the study by O¨sterberg et al.39, which
was conducted in elderly patients (70 years) in Sweden and
which evaluated the association between mortality and
number of teeth over a period of seven years in both sexes.
After adjustment for covariates, such as factors related to
health and socioeconomic and lifestyle parameters, the
authors found that the number of teeth was an independent
predictor of mortality and that each remaining tooth was
associated with a 4% decrease in mortality risk.
CP is associated with altered endothelial function, which
improves after treatment. The fact that CP can result in lower
bioavailability of nitric oxide and endothelium disfunction40
may explain, together with other factors, the higher systolic
and diastolic blood pressure in the patients with CP and CKD.
This study had limitations: (i) the qualitative PCR technique
used in our study did not allow quantification of the
microorganisms identified or even an identification of sub-
types; (ii) samples were collected from a single tooth site (most
inflamed) and not from all sites of the mouth; and (iii) the
cross-sectional nature of the study limited its ability to
determine the effects of CP on the outcome of CKD.
In summary, this study showed that red-complex bacteria
(P. gingivalis, T. forsythia, T. denticola) and C. albicans were more
frequent in patients with CP and CKD than in healthy
individuals. Additionally, CP was more severe in patients
with CKD than in healthy controls. These findings highlight
the importance of regular examination of the oral cavity in
patients with CKD for early detection and treatment of CP
which can contribute to the inflammatory burden in CKD
patients.
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